Back to Search Start Over

Biktarvy Label Update Adds Data on Safety, Efficacy in Pregnant HIV Patients

Authors :
Ernst, Diana
Source :
Clinical Advisor. May 2, 2024
Publication Year :
2024

Abstract

The Food and Drug Administration (FDA) has approved updated labeling for https://www.empr.com/drug/biktarvy/ (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg) to include additional data regarding pregnant patients with HIV-1 who are virologically-suppressed (HIV-1 [...]

Subjects

Subjects :
HIV (Viruses)
HIV patients
Emtricitabine -- Labeling
Health
Biktarvy (Medication) -- Labeling

Details

Language :
English
ISSN :
15247317
Database :
Gale General OneFile
Journal :
Clinical Advisor
Publication Type :
Periodical
Accession number :
edsgcl.792285391

Tools

Authors Abstract Subjects Details